Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.370
+0.020 (1.48%)
At close: Jul 11, 2025, 4:00 PM
1.370
0.00 (0.00%)
After-hours: Jul 11, 2025, 4:28 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $92.58 million as of July 11, 2025. Its market cap has decreased by -58.89% in one year.
Market Cap
92.58M
Enterprise Value
-104.79M
1-Year Change
-58.89%
Ranking
Category
Stock Price
1.37
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $92.58M, a decrease of -77.04%. That is a compound annual growth rate of -31.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 91.23M | -24.61% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |